Erasca, Inc. Common Stock (ERAS) is a publicly traded Healthcare sector company. As of September 8, 2026, ERAS trades at $16.20 with a market cap of $5.66B and a P/E ratio of -36.80. ERAS moved +0.00% today. Year to date, ERAS is +335.21%; over the trailing twelve months it is +905.59%. Its 52-week range spans $1.01 to $24.28. Analyst consensus is strong buy with an average price target of $24.13. Rallies surfaces ERAS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest ERAS news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $16.20 |
| Market Cap | $5.66B |
| P/E Ratio | -36.80 |
| EPS | $-0.44 |
| Dividend Yield | 0.00% |
| 52-Week High | $24.28 |
| 52-Week Low | $1.01 |
| Volume | 17.26K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-124.55M |
| Gross Margin | 0.00% |
8 analysts cover ERAS: 0 strong buy, 6 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $24.13.